| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |